Background: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis named ANCA-associated-vasculities (AAV). We herein report 3 patients with SE and positivity to p-ANCA.Case presentation: One patient had a catastrophic evolution and died 5 months after disease onset. The other two patients had a good outcome and remained seizure-free at 30 months and 5 years of follow-up respectively.Conclusion: This report highlights the importance of considering ANCA dosage in patients with SE of unclear origin. © 2014 Ferlazzo et al.; licensee BioMed Central Ltd.
CITATION STYLE
Ferlazzo, E., Gambardella, A., Bellavia, M., Gasparini, S., Mumoli, L., Labate, A., … Aguglia, U. (2014). Positivity to p-ANCA in patients with status epilepticus. BMC Neurology, 14(1). https://doi.org/10.1186/1471-2377-14-148
Mendeley helps you to discover research relevant for your work.